Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluation of Topically Applied Bemotrizinol for Human Phototoxic Potential

NCT05254925 is registered in ClinicalTrials.gov with dsm-firmenich Switzerland AG as lead sponsor.

NCT NCT05254925
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05254925 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluation of Topically Applied Bemotrizinol for Human Phototoxic Potential
Lead sponsor
dsm-firmenich Switzerland AG
Phase
Phase 2
Overall status
Completed
Start date
February 28, 2022
Completion date
April 3, 2022
Enrollment
34 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

phototoxic response